Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-line Antibiotics for Early-stage H. Pylori-Positive Gastric DLBCL
NCT02388581Phase 2Unknown
- Sponsor
- National Health Research Institutes
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lansoprazole, amoxicillin, clarithromycin, metronidazole in diffuse large B-cell lymphoma (PG-DLBCL), sponsored by National Health Research Institutes. Status: unknown.
02
Drugs
lansoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
diffuse large B-cell lymphoma (PG-DLBCL)
Beyond the preview
Go deeper on NCT02388581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388581.